companydata.dkLICA PHARMACEUTICALS ApS: Financial statements 2019
CVR: 25332520
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 279,654 and a net result of DKK 2,782,288 compared with DKK 5,572,310 the year before. That is a decrease of 71.3% compared with the year before. Equity amounted to DKK 18,750,054. The solvency ratio was 99.3%.
- Gross Profit
- 279,654 kr.
- Profit/Loss
- 2,782,288 kr.
- Equity
- 18,750,054 kr.
- Total Assets
- 18,891,663 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 280 t. | 2.8 mio. | 18.8 mio. | - |
| 2018 | - | 973 t. | 5.6 mio. | 18.4 mio. | - |
| 2017 | - | 409 t. | 812 t. | 12.8 mio. | - |
| 2016 | - | 738 t. | 328 t. | 12 mio. | - |
| 2015 | - | 312 t. | -2.3 mio. | 11.7 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
LICA PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK 973,018, and the net result was DKK 5,572,310.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.